Twenty-year survivors of kidney transplantation

American Journal of Transplantation

Volumn 12, Issue 12, 2012, Pages 3289-3295

  Traynor, C ^a   Jenkinson, A ^b   Williams, Y ^a   O'Kelly, P ^a   Hickey, D ^a   Denton, M ^a   Magee, C ^a   Conlon, P J ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Cyclosporine; kidney transplant; living related transplantation; long term allograft survival

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN; METHYLPREDNISOLONE; OKT 3; PREDNISOLONE; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL FEATURE; COMORBIDITY; CREATININE BLOOD LEVEL; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY ALLOGRAFT; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; LIVING DONOR; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN CANCER; SURVIVOR;

EID: 84870571038     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04236.x     Document Type: Article

References (16)

1. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D,. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605-612.
2. Serur D, Saal S, Wang J, et al,. Deceased donor kidney transplantation: Improvement in long-term survival. Nephrol Dial Transplant 2011; 26: 317-324.
3. Braun WE, Yadlapalli NG,. The spectrum of long-term renal transplantation: Outcomes, complications, and clinical studies. Transplant Reviews. 2002; 16: 22-50.
4. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B,. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378-383.
5. Lamb KE, Lodhi S, Meier-Kriesche HU,. Long-term renal allograft survival in the United States: A critical reappraisal. Am J Transplant 2011; 11: 450-462.
6. Conlon PJ, Medwar W, Hanson S, Donohoe J, Carmody M, Walshe JJ,. Long term outcome of renal transplantation in the pre cyclosporin era: One centre's experience. Ir J Med Sci. 1995; 164: 109-112.
7. Matas A, Gillingham K,., Humar A, et al,. 2,202 kidney transplant recipients with 10 years of graft function: What happens next? Am J Transplant 2008; 8: 2410-2419.
8. Meier-Kriesche HU, Ojo AO, Leavey SF, et al,. Gender differences in the risk for chronic renal allograft failure. Transplantation 2001; 71: 42.
9. Moreso F, Seron D, Gil-Vernet S, et al,. Donor age and delayed graft function as predictors of renal allograft survival in rejection-free patients. Nephrology, dialysis, transplantation. 1999; 14: 930-935.
10. Veroux M, Grosso G, Corona D, et al,. Age is an important predictor of kidney transplantation outcome. Nephrol Dial Transplant 2011; 0: 1-9 doi: 10.1093/ndt/gfr524
11. Naesens M, Kuypers DR, Sarwal M,. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009; 4: 481-508.
12. Gallagher M, Jardine M, Perkovic V, et al,. Cyclosporine withdrawal improves long term outcomes in renal transplantation. Transplantation 2009; 87: 1877-1883.
13. OPTN. Organ Procurement and Transplantation Network. 2011, Available at: http://optn.transplant.hrsa.gov/.
14. Moloney F, Comber H, O'Lorcain P, O'Kelly P, Conlon P, Murphy G,. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006; 154: 498-504.
15. Berehi L, Pallett N, Zuber J, et al,. Clinical and immunological features of very long term survivors with a single renal transplant. Transplant International 2012; 25: 545-554.
16. Gallagher M, Kellp P, Jardine M, et al,. Long-term cancer risk of immunosuppressive regimes after kidney transplantation. J Am Soc Nephrol 2010; 21: 852-858.